Natco Pharma started in Hyderabad with an investment of ₹3.3 million in 1981 and 20 employees working at a single unit. Today ...

The stock rose 2.95 per cent to hit a high of Rs 789. It was last seen trading 1.44 per cent up at Rs 777.45. At this price, it has crashed 44.42 per cent on a year-to-date (YTD) basis.

Newgen Software Technologies Ltd, Natco Pharma Ltd, MMTC Ltd and Sonata Software Ltd are among the other gainers in the BSE's 'A' group today, 24 April 2025.

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.<br/><br/> <table border=' ...

Benchmark NSE Nifty50 index was down 35.96 points at 24293.0, while the BSE Sensex was down 126.34 points at 79990.15. Among ...

Natco Pharma plans to launch generic Risdiplam pending Delhi High Court decision, offering discounts to patients.

Natco Pharma, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹826.85. The stock has experienced fluctuations today, with a low ...

Syngene International Ltd registered volume of 168.31 lakh shares by 14:14 IST on NSE, a 34.31 fold spurt over two-week average daily volume of 4.91 lakh shares ...

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF ...

Natco Pharma has decided to price Risdiplam, indicated for the treatment of rare genetic disorder Spinal Muscular Atrophy (SMA), at₹15,900. In an update on the legal proceedings on the ...